Search

Search Constraints

You searched for: Author/Creator Shulman, Matisyahu

Search Results

2. Baseline‐ and treatment‐associated pain in the X:BOT comparative effectiveness study of extended‐release naltrexone versus buprenorphine‐naloxone for OUD. (7th December 2021)

6. Cost‐effectiveness implications of increasing the efficiency of the extended‐release naltrexone induction process for the treatment of opioid use disorder: a secondary analysis. (21st May 2021)

7. Explaining differential effects of medication for opioid use disorder using a novel approach incorporating mediating variables. (22nd January 2021)

9. Methamphetamine/amphetamine use over time among persons with opioid use disorders treated with buprenorphine/naloxone versus extended-release naltrexone. (1st July 2022)

10. Neurocognitive Profiling of Adult Treatment Seekers Enrolled in a Clinical Trial of a Web-delivered Intervention for Substance Use Disorders. Issue 2 (March 2018)